Abbott Laboratories (LON:0Q15)
128.88
+0.52 (0.41%)
At close: Nov 24, 2025
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of 168.9 billion as of November 26, 2025. Its market cap has increased by 7.95% in one year.
Market Cap
168.90B
Enterprise Value
173.11B
Revenue
32.62B
Ranking
n/a
PE Ratio
16.30
Stock Price
128.88
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 168.90B, an increase of 26,445.32%. That is a compound annual growth rate of 10.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 168.90B | 7.78% |
| Dec 31, 2024 | 156.71B | 4.46% |
| Dec 29, 2023 | 150.02B | -5.57% |
| Dec 30, 2022 | 158.87B | -10.87% |
| Dec 31, 2021 | 178.25B | 29.73% |
| Dec 31, 2020 | 137.41B | 18.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.08B |
| HSBC Holdings | 179.96B |
| Shell | 159.61B |
| Unilever | 112.58B |
| British American Tobacco p.l.c. | 91.27B |
| Rio Tinto Group | 90.80B |
| Rolls-Royce Holdings | 86.18B |
| GSK plc | 72.12B |